{"id":93897,"topic":"peptides","source":"新浪财经","title":"诺和诺德CEO：尚未对多肽热潮表示认同 - 新浪财经","url":"https://finance.sina.com.cn/stock/usstock/c/2026-09-08/doc-inircrnn9212070.shtml?finpagefr=p_108","url_hash":"dff16edf7f919dc829ead8fd42c3220b1b055849","author":"","summary":"<a href=\"https://news.google.com/rss/articles/CBMinAFBVV95cUxOc3FjZTNyR0c4VmNXV3FxY2t1THRhYXp3dUdrUDBJNkFsc2JwLUZPUUwxcFdzMFVZZE5hRUNFaEFtOXpjSFAtd09vNEFUN2VwVzVaeXNSRFJNVkk5cl9fcWFxRXlwY09TQ011Rks5WFZzYTU3Nk5FR3h4Z3F4RjJqT2gtdVdiQUpYZDZzMUhEdTVsbUUtOWVRMEh2a3Y?oc=5\" target=\"_blank\">诺和诺德CEO：尚未对多肽热潮表示认同</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">新浪财经</font>","content":"ããè¯ºåè¯ºå¾·\nããä½å¯¹äºå¤è½é¢åå°ä¸å¸åºçä¹±è±¡ï¼ä»å´æåº¦å·æ·¡ãä¸å°ç½çº¢åä¸»è´ä¹°æªç»æ£éªçå¤è½éåç¨æ¥æ¹åç®è¤ç¶æï¼å¥èº«ç±å¥½è ä¹ä¹°æ¥è¿ç±»äº§åï¼å¸æå¿«éåèã\nããææ¯è¾¾å°å¨ãä¸çå¤§åè®¿è°ãææ°ä¸ææå®¢èç®ä¸è¡¨ç¤ºï¼âå¸é¢ä¸æå¤§éè¿ç±»å¤è½äº§åï¼å®ä»¬ä¸å Wegovy çåãä¹ä¸åæä»¬çè°å²ç´ ï¼å®å ¨æ²¡æç»è¿éªè¯ãå å ¶éåªåè¿é¨åå¨ç©å®éªï¼åªè§å¯è¿å¨å¤§é¼ ãå°é¼ èº«ä¸çååºï¼æ ¹æ¬æ²¡æå¼å±äººä½ä¸´åºè¯éªãå»è¯è¡ä¸çç®¡ååå¿ è¦ï¼å ä¸ºè¯ç©ä¼äº§çä¸¥éå¯ä½ç¨ãè¦ç¥éï¼è¯¯ç¨è¯ç©æ¯ä¼è´äººæ»äº¡çãè¿å¯ä¸æ¯ä¹°ä¸ªé«ä»¿å¤é©°å é£ä¹ç®åï¼ä¼å¸¦æ¥å®å®å¨å¨çä¸¥éåæãâ\nããææ¯è¾¾å°è®¤ä¸ºï¼ç¾å½é£åè¯åçç£ç®¡çå±ï¼FDAï¼åºå½å¯¹è¿ç±»å¤è½å®æ½çç®¡ã\nããâè¿äºäº§åæ²¡æç»è¿éªè¯ï¼æä»¥æççæ¡æ¯ï¼æä¸ç¥éå®ä»¬å®ä¸å®å ¨ãæèªå·±ç»å¯¹ä¸ä¼å»åè¿ä¸ªé£é©ãå®ä»¬æè®¸ææï¼æè®¸æèé£é©ï¼ä¹å¯è½ä¸¤è çæ ãä½ä¸ºä»ä¹è¦ç¨èªå·±çèº«ä½åå¥åº·å»åè¿ä¹å¤§çé£é©ï¼â\nããä»è¡¥å éï¼âå½ç¶ï¼æä¸å¦è®¤æªæ¥é¨åå¤è½ååçåºç±è¯ä¼å®æè§èæµè¯ï¼èµ°å® FDA ä»¥ååé¡¹çç®¡æµç¨ãå¦æç¡®å®åå¨å¸åºéæ±ï¼é£å°±å¼å±è¯éªï¼æ¨åºå®å ¨åè§ççæ¬ï¼èä¸æ¯æ¿äººèº«å®å ¨å»èµåãâ\nããåç¤¾äº¤åªä½é£æ½®ãåéè¯ç©èµ°çº¢å¸¦å¨ï¼ä¸»æçç©é»å®¢ä¸å »çåæçå¤è½ï¼ä¾å¦ BPCâ157ãTBâ500ï¼å¸åºç«çãä¸å°æ¶è´¹è å¯å¸æäºå®ä»¬å®ç°æè¡°èãæä¼¤ä¿®å¤ãå¢èçææã\nããæ¤å FDA å°å¤§éæªè·æ¹å¤è½åå ¥ç®¡æ§æ¸ åï¼ç¦æ¢è¯æ¿èªè¡è°é ãäºæ¯æ°ç¾ä¸ç¨æ·è½¬åå®å ¨æ²¡æçç®¡çé»å¸ä¸ç°å¸æ¸ éã\nããé¢å¯¹ç°ç¶ï¼ç¾å½å«çä¸å ¬ä¼æå¡é¨é¨é¿ç½ä¼¯ç¹ã»è¯å°¼è¿ªäºä¸èªç§°æ¯å¤è½çå¿ å®ä½¿ç¨è ï¼ä»æ¨å¨éå¤§æ¿çè½¬åï¼ææ¤é FDA å¯¹çº¦ 14 ç§çé¨å¤è½çéå¶ã\nããè¯å°¼è¿ªè®¤ä¸ºï¼æ¤åççç®¡ç¦ä»¤æ¬èº«å¹¶ä¸åæ³ï¼åèå¬çäºå±é©çå°ä¸å¸åºï¼éæ°å½ç±»ãå è®¸æ£è§è¯æ¿åè§è°é ï¼æå¯ä»¥è®©æ°ä¼è·å¾åçç®¡çäº§åã\nããææ¯è¾¾å°äº 2025 å¹´ 8 æåºä»»è¯ºåè¯ºå¾· CEOï¼æ¥æ¿ä»»èå¤å¹´çææ¯ã»å¼é²é«ã»çº¦æ ¹æ£®ã1992 å¹´ä»å¨ç»´ä¹çº³ä»¥æ®éåå ¬å®¤æåèº«ä»½å ¥èè¯ºåè¯ºå¾·ï¼åç» 33 å¹´æåï¼æç»æ§æè¿å®¶å·¨å¤´ã\nãã2015 å¹´ä»åä»»å½é ä¸å¡æ§è¡å¯æ»è£ï¼å ¨é¢æç®¡ç¾å½ä»¥å¤å ¨é¨åä¸çå¾ï¼å¸¦é¢è¯¥æ¿åå®ç°éå®é¢ç¿»åã\nããå¦ä»ï¼ææ¯è¾¾å°æèµè¿å®¶å»çå·¨å¤´ï¼ç´é¢ GLPâ1 èµéæ¿çç«äºï¼ä¸»è¦å¯¹æä¸ºç¤¼æ¥\nããææ¯è¾¾å°è¡¨ç¤ºï¼ä¸æ¹é¢è¦ä¼å Wegovy è¥éï¼åæ¶ç»§ç»æ¨å¨å£æç Wegovy æ¾éï¼ä¸å£åº¦å£æçäº§åä¸ç»©ä¸ååæå¸é¢æãå¦å¤ï¼ä»æ£å å¤§ç åæå ¥ï¼åºå¯¹æªæ¥æ°å¹´å¤æ¬¾ä¸å©å°æçææã\nããä¸è¿°ä¸¾æªè½å¦è½å°ï¼å¯¹ä¿®å¤è¯ºåè¯ºå¾·å¨åå°è¡ç¼ä¸çå½¢è±¡è³å ³éè¦ã\nããè¿å»ä¸å¹´ï¼è¯ºåè¯ºå¾·è¡ä»·ç´¯è®¡ä¸è· 17%ï¼åææ æ® 500 ææ°ä¸æ¶¨ 19%ï¼ç¤¼æ¥è¡ä»·å¤§æ¶¨ 57%ã\nããé«ç\nè´£ä»»ç¼è¾ï¼éæç \nVIPè¯¾ç¨æ¨è\nAPPä¸äº«ç´æ\nçé¨æ¨è\næ¶èµ·24å°æ¶æ»å¨ææ¥ææ°çè´¢ç»èµè®¯åè§é¢ï¼æ´å¤ç²ä¸ç¦å©æ«æäºç»´ç å ³æ³¨ï¼sinafinanceï¼","image_url":"//n.sinaimg.cn/finance/transform/116/w550h366/20260908/da4b-79d9afc0d593a1a06aa274dbff8a7e64.png","lang":"zh","published_at":"2026-09-08T07:00:00+00:00","fetched_at":"2026-10-01T01:15:11+00:00","status":"read","starred":0,"extract_state":"ok","summary_auto":"ããè¯ºåè¯ºå¾·\nããä½å¯¹äºå¤è½é¢åå°ä¸å¸åºçä¹±è±¡ï¼ä»å´æåº¦å·æ·¡ãä¸å°ç½çº¢åä¸»è´ä¹°æªç»æ£éªçå¤è½éåç¨æ¥æ¹åç®è¤ç¶æï¼å¥èº«ç±å¥½è ä¹ä¹°æ¥è¿ç±»äº§åï¼å¸æå¿«éåèã\nããææ¯è¾¾å°å¨ãä¸çå¤§åè®¿è°ãææ°ä¸ææå®¢èç®ä¸è¡¨ç¤ºï¼âå¸é¢ä¸æå¤§éè¿ç±»å¤è½äº§åï¼å®ä»¬ä¸å Wegovy çåãä¹ä¸åæä»¬çè°å²ç´ ï¼å®å ¨æ²¡æç»è¿éªè¯ãå å ¶éåªåè¿é¨åå¨ç©å®éªï¼åªè§å¯è¿å¨å¤§é¼ ãå°é¼ èº«ä¸çååºï¼æ ¹æ¬æ²¡æå¼å±äººä½ä¸´åºè¯éªãå»è¯è¡ä¸çç®¡ååå¿ è¦ï¼å ä¸ºè¯ç©ä¼äº§çä¸¥éå¯ä½ç¨ãè¦ç¥éï¼è¯¯ç¨è¯ç©æ¯ä¼è´äººæ»äº¡çãè¿å¯ä¸æ¯ä¹°ä¸ªé«ä»¿å¤é©°å é£ä¹ç®åï¼ä¼å¸¦æ¥å®å®å¨å¨çä¸¥éåæãâ\nããææ¯è¾¾å°è®¤ä¸ºï¼ç¾å½é£åè¯åçç£ç®¡çå±ï¼FDAï¼åºå½å¯¹è¿ç±»å¤è½å®æ½çç®¡ã\nããâè¿äºäº§åæ²¡æç»è¿éªè¯ï¼æä»¥æççæ¡æ¯ï¼æä¸ç¥éå®ä»¬å®ä¸å®å ¨ãæèªå·±ç»å¯¹ä¸ä¼å»åè¿ä¸ªé£é©ãå®ä»¬æè®¸ææï¼æè®¸æèé£é©ï¼ä¹å¯è½ä¸¤è çæ ãä½ä¸ºä»ä¹è¦ç¨èªå·±çèº«ä½åå¥åº·å»åè¿ä¹å¤§çé£é©ï¼â\nããä»è¡¥å éï¼âå½ç¶ï¼æä¸å¦è®¤æªæ¥é¨åå¤è½ååçåºç±è¯ä¼å®æè§èæµè¯ï¼èµ°å® FDA ä»¥ååé¡¹çç®¡æµç¨ãå¦æç¡®å®åå¨å¸åºéæ±ï¼é£å°±å¼å±è¯éªï¼æ¨åºå®å ¨åè§ççæ¬ï¼èä¸æ¯æ¿äººèº«å®å ¨å»èµåãâ\nããåç¤¾äº¤åªä½é£æ½®ãåéè¯ç©èµ°çº¢å¸¦å¨ï¼ä¸»æçç©é»å®¢ä¸å »çåæçå¤è½ï¼ä¾å¦ BPCâ157ãTBâ500ï¼å¸åºç«çãä¸å°æ¶è´¹è å¯å¸æäºå®ä»¬å®ç°æè¡°èãæä¼¤ä¿®å¤ãå¢èçææã\nããæ¤å FDA å°å¤§éæªè·æ¹å¤è½åå ¥ç®¡æ§æ¸ åï¼ç¦æ¢è¯æ¿èªè¡è°é ãäºæ¯æ°ç¾ä¸ç¨æ·è½¬åå®å ¨æ²¡æçç®¡çé»å¸ä¸ç°å¸æ¸ éã\nããé¢å¯¹ç°ç¶ï¼ç¾å½å«çä¸å ¬ä¼æå¡é¨é¨é¿ç½ä¼¯ç¹ã»è¯å°¼è¿ªäºä¸èªç§°æ¯å¤è½çå¿ å®ä½¿ç¨è ï¼ä»æ¨å¨éå¤§æ¿çè½¬åï¼ææ¤é FDA å¯¹çº¦ 14 ç§çé¨å¤è½çéå¶ã\nããè¯å°¼è¿ªè®¤ä¸ºï¼æ¤åççç®¡ç¦ä»¤æ¬èº«å¹¶ä¸åæ³ï¼åèå¬çäºå±é©çå°ä¸å¸åºï¼éæ°å½ç±»ãå è®¸æ£è§è¯æ¿åè§è°é ï¼æå¯ä»¥è®©æ°ä¼è·å¾åçç®¡çäº§åã\nããææ¯è¾¾å°äº 2025 å¹´ 8 æåºä»»è¯ºåè¯ºå¾· CEOï¼æ¥æ¿ä»»èå¤å¹´çææ¯ã»å¼é²é«ã»çº¦æ ¹æ£®ã1992 å¹´ä»å¨ç»´ä¹çº³ä»¥æ®éåå ¬å®¤æåèº«ä»½å ¥èè¯ºåè¯ºå¾·ï¼åç» 33 å¹´æåï¼æç»æ§æè¿å®¶å·¨å¤´ã\nãã2015 å¹´ä»åä»»å½é ä¸å¡æ§è¡å¯æ»è£ï¼å ¨é¢æç®¡ç¾å½ä»¥å¤å ¨é¨åä¸çå¾ï¼å¸¦é¢è¯¥æ¿åå®ç°éå®é¢ç¿»åã\nããå¦ä»ï¼ææ¯è¾¾å°æèµè¿å®¶å»çå·¨å¤´ï¼ç´é¢ GLPâ1 èµéæ¿çç«äºï¼ä¸»è¦å¯¹æä¸ºç¤¼æ¥\nããææ¯è¾¾å°è¡¨ç¤ºï¼ä¸æ¹é¢è¦ä¼å Wegovy è¥éï¼åæ¶ç»§ç»æ¨å¨å£æç Wegovy æ¾éï¼ä¸å£åº¦å£æçäº§åä¸ç»©ä¸ååæå¸é¢æãå¦å¤ï¼ä»æ£å å¤§ç åæå ¥ï¼åºå¯¹æªæ¥æ°å¹´å¤æ¬¾ä¸å©å°æçææã\nããä¸è¿°ä¸¾æªè½å¦è½å°ï¼å¯¹ä¿®å¤è¯ºåè¯ºå¾·å¨åå°è¡ç¼ä¸çå½¢è±¡è³å ³éè¦ã\nããè¿å»ä¸å¹´ï¼è¯ºåè¯ºå¾·è¡ä»·ç´¯è®¡ä¸è· 17%ï¼åææ æ® 500 ææ°ä¸æ¶¨ 19%ï¼ç¤¼æ¥è¡ä»·å¤§æ¶¨ 57%ã\nããé«ç\nè´£ä»»ç¼è¾ï¼éæç \nVIPè¯¾ç¨æ¨è\nAPPä¸äº«ç´æ\nçé¨æ¨è\næ¶èµ·24å°æ¶æ»å¨ææ¥ææ°çè´¢ç»èµè®¯åè§é¢ï¼æ´å¤ç²ä¸ç¦å©æ«æäºç»´ç å ³æ³¨ï¼sinafinanceï¼","cluster_id":3538506,"extract_retries":0,"extract_error":null,"contract_version":"news_item.v1","format_contract_version":"news_item_formats.v1","dedup_url":"https://finance.sina.com.cn/stock/usstock/c/2026-09-08/doc-inircrnn9212070.shtml?finpagefr=p_108","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 2228 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":2228,"summary_length":2228,"usable_text_length":2228,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":2228,"summary_length":2228}},"news_item":{"id":93897,"canonical_url":"https://finance.sina.com.cn/stock/usstock/c/2026-09-08/doc-inircrnn9212070.shtml?finpagefr=p_108","source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-09-08/doc-inircrnn9212070.shtml?finpagefr=p_108","title":"诺和诺德CEO：尚未对多肽热潮表示认同 - 新浪财经","source_name":"新浪财经","author":null,"published_at":"2026-09-08T07:00:00+00:00","locale":"zh","topic":"peptides","tags":[],"rss_summary":"<a href=\"https://news.google.com/rss/articles/CBMinAFBVV95cUxOc3FjZTNyR0c4VmNXV3FxY2t1THRhYXp3dUdrUDBJNkFsc2JwLUZPUUwxcFdzMFVZZE5hRUNFaEFtOXpjSFAtd09vNEFUN2VwVzVaeXNSRFJNVkk5cl9fcWFxRXlwY09TQ011Rks5WFZzYTU3Nk5FR3h4Z3F4RjJqT2gtdVdiQUpYZDZzMUhEdTVsbUUtOWVRMEh2a3Y?oc=5\" target=\"_blank\">诺和诺德CEO：尚未对多肽热潮表示认同</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">新浪财经</font>","full_text":"ããè¯ºåè¯ºå¾·\nããä½å¯¹äºå¤è½é¢åå°ä¸å¸åºçä¹±è±¡ï¼ä»å´æåº¦å·æ·¡ãä¸å°ç½çº¢åä¸»è´ä¹°æªç»æ£éªçå¤è½éåç¨æ¥æ¹åç®è¤ç¶æï¼å¥èº«ç±å¥½è ä¹ä¹°æ¥è¿ç±»äº§åï¼å¸æå¿«éåèã\nããææ¯è¾¾å°å¨ãä¸çå¤§åè®¿è°ãææ°ä¸ææå®¢èç®ä¸è¡¨ç¤ºï¼âå¸é¢ä¸æå¤§éè¿ç±»å¤è½äº§åï¼å®ä»¬ä¸å Wegovy çåãä¹ä¸åæä»¬çè°å²ç´ ï¼å®å ¨æ²¡æç»è¿éªè¯ãå å ¶éåªåè¿é¨åå¨ç©å®éªï¼åªè§å¯è¿å¨å¤§é¼ ãå°é¼ èº«ä¸çååºï¼æ ¹æ¬æ²¡æå¼å±äººä½ä¸´åºè¯éªãå»è¯è¡ä¸çç®¡ååå¿ è¦ï¼å ä¸ºè¯ç©ä¼äº§çä¸¥éå¯ä½ç¨ãè¦ç¥éï¼è¯¯ç¨è¯ç©æ¯ä¼è´äººæ»äº¡çãè¿å¯ä¸æ¯ä¹°ä¸ªé«ä»¿å¤é©°å é£ä¹ç®åï¼ä¼å¸¦æ¥å®å®å¨å¨çä¸¥éåæãâ\nããææ¯è¾¾å°è®¤ä¸ºï¼ç¾å½é£åè¯åçç£ç®¡çå±ï¼FDAï¼åºå½å¯¹è¿ç±»å¤è½å®æ½çç®¡ã\nããâè¿äºäº§åæ²¡æç»è¿éªè¯ï¼æä»¥æççæ¡æ¯ï¼æä¸ç¥éå®ä»¬å®ä¸å®å ¨ãæèªå·±ç»å¯¹ä¸ä¼å»åè¿ä¸ªé£é©ãå®ä»¬æè®¸ææï¼æè®¸æèé£é©ï¼ä¹å¯è½ä¸¤è çæ ãä½ä¸ºä»ä¹è¦ç¨èªå·±çèº«ä½åå¥åº·å»åè¿ä¹å¤§çé£é©ï¼â\nããä»è¡¥å éï¼âå½ç¶ï¼æä¸å¦è®¤æªæ¥é¨åå¤è½ååçåºç±è¯ä¼å®æè§èæµè¯ï¼èµ°å® FDA ä»¥ååé¡¹çç®¡æµç¨ãå¦æç¡®å®åå¨å¸åºéæ±ï¼é£å°±å¼å±è¯éªï¼æ¨åºå®å ¨åè§ççæ¬ï¼èä¸æ¯æ¿äººèº«å®å ¨å»èµåãâ\nããåç¤¾äº¤åªä½é£æ½®ãåéè¯ç©èµ°çº¢å¸¦å¨ï¼ä¸»æçç©é»å®¢ä¸å »çåæçå¤è½ï¼ä¾å¦ BPCâ157ãTBâ500ï¼å¸åºç«çãä¸å°æ¶è´¹è å¯å¸æäºå®ä»¬å®ç°æè¡°èãæä¼¤ä¿®å¤ãå¢èçææã\nããæ¤å FDA å°å¤§éæªè·æ¹å¤è½åå ¥ç®¡æ§æ¸ åï¼ç¦æ¢è¯æ¿èªè¡è°é ãäºæ¯æ°ç¾ä¸ç¨æ·è½¬åå®å ¨æ²¡æçç®¡çé»å¸ä¸ç°å¸æ¸ éã\nããé¢å¯¹ç°ç¶ï¼ç¾å½å«çä¸å ¬ä¼æå¡é¨é¨é¿ç½ä¼¯ç¹ã»è¯å°¼è¿ªäºä¸èªç§°æ¯å¤è½çå¿ å®ä½¿ç¨è ï¼ä»æ¨å¨éå¤§æ¿çè½¬åï¼ææ¤é FDA å¯¹çº¦ 14 ç§çé¨å¤è½çéå¶ã\nããè¯å°¼è¿ªè®¤ä¸ºï¼æ¤åççç®¡ç¦ä»¤æ¬èº«å¹¶ä¸åæ³ï¼åèå¬çäºå±é©çå°ä¸å¸åºï¼éæ°å½ç±»ãå è®¸æ£è§è¯æ¿åè§è°é ï¼æå¯ä»¥è®©æ°ä¼è·å¾åçç®¡çäº§åã\nããææ¯è¾¾å°äº 2025 å¹´ 8 æåºä»»è¯ºåè¯ºå¾· CEOï¼æ¥æ¿ä»»èå¤å¹´çææ¯ã»å¼é²é«ã»çº¦æ ¹æ£®ã1992 å¹´ä»å¨ç»´ä¹çº³ä»¥æ®éåå ¬å®¤æåèº«ä»½å ¥èè¯ºåè¯ºå¾·ï¼åç» 33 å¹´æåï¼æç»æ§æè¿å®¶å·¨å¤´ã\nãã2015 å¹´ä»åä»»å½é ä¸å¡æ§è¡å¯æ»è£ï¼å ¨é¢æç®¡ç¾å½ä»¥å¤å ¨é¨åä¸çå¾ï¼å¸¦é¢è¯¥æ¿åå®ç°éå®é¢ç¿»åã\nããå¦ä»ï¼ææ¯è¾¾å°æèµè¿å®¶å»çå·¨å¤´ï¼ç´é¢ GLPâ1 èµéæ¿çç«äºï¼ä¸»è¦å¯¹æä¸ºç¤¼æ¥\nããææ¯è¾¾å°è¡¨ç¤ºï¼ä¸æ¹é¢è¦ä¼å Wegovy è¥éï¼åæ¶ç»§ç»æ¨å¨å£æç Wegovy æ¾éï¼ä¸å£åº¦å£æçäº§åä¸ç»©ä¸ååæå¸é¢æãå¦å¤ï¼ä»æ£å å¤§ç åæå ¥ï¼åºå¯¹æªæ¥æ°å¹´å¤æ¬¾ä¸å©å°æçææã\nããä¸è¿°ä¸¾æªè½å¦è½å°ï¼å¯¹ä¿®å¤è¯ºåè¯ºå¾·å¨åå°è¡ç¼ä¸çå½¢è±¡è³å ³éè¦ã\nããè¿å»ä¸å¹´ï¼è¯ºåè¯ºå¾·è¡ä»·ç´¯è®¡ä¸è· 17%ï¼åææ æ® 500 ææ°ä¸æ¶¨ 19%ï¼ç¤¼æ¥è¡ä»·å¤§æ¶¨ 57%ã\nããé«ç\nè´£ä»»ç¼è¾ï¼éæç \nVIPè¯¾ç¨æ¨è\nAPPä¸äº«ç´æ\nçé¨æ¨è\næ¶èµ·24å°æ¶æ»å¨ææ¥ææ°çè´¢ç»èµè®¯åè§é¢ï¼æ´å¤ç²ä¸ç¦å©æ«æäºç»´ç å ³æ³¨ï¼sinafinanceï¼","excerpt":"ããè¯ºåè¯ºå¾·\nããä½å¯¹äºå¤è½é¢åå°ä¸å¸åºçä¹±è±¡ï¼ä»å´æåº¦å·æ·¡ãä¸å°ç½çº¢åä¸»è´ä¹°æªç»æ£éªçå¤è½éåç¨æ¥æ¹åç®è¤ç¶æï¼å¥èº«ç±å¥½è ä¹ä¹°æ¥è¿ç±»äº§åï¼å¸æå¿«éåèã\nããææ¯è¾¾å°å¨ãä¸çå¤§åè®¿è°ãææ°ä¸ææå®¢èç®ä¸è¡¨ç¤ºï¼âå¸é¢ä¸æå¤§éè¿ç±»å¤è½äº§åï¼å®ä»¬ä¸å Wegovy çåãä¹ä¸åæä»¬çè°å²ç´ ï¼å®å ¨æ²¡æç»è¿éªè¯ãå å ¶éåªåè¿é¨åå¨ç©å®éªï¼åªè§å¯è¿å¨å¤§é¼ ãå°é¼ èº«ä¸çååºï¼æ ¹æ¬æ²¡æå¼å±äººä½ä¸´åºè¯éªãå»è¯è¡ä¸çç®¡ååå¿ è¦ï¼å ä¸ºè¯ç©ä¼äº§çä¸¥éå¯ä½ç¨ãè¦ç¥éï¼è¯¯ç¨è¯ç©æ¯ä¼è´äººæ»äº¡çãè¿å¯ä¸æ¯ä¹°ä¸ªé«ä»¿å¤é©°å é£ä¹ç®åï¼ä¼å¸¦æ¥å®å®å¨å¨çä¸¥éåæãâ\nããææ¯è¾¾å°è®¤ä¸ºï¼ç¾å½é£åè¯åçç£ç®¡çå±ï¼FDAï¼åºå½å¯¹è¿ç±»å¤è½å®æ½çç®¡ã\nããâè¿äºäº§åæ²¡æç»è¿éªè¯ï¼æä»¥æççæ¡æ¯ï¼æä¸ç¥éå®ä»¬å®ä¸å®å ¨ãæèªå·±ç»å¯¹ä¸ä¼å»åè¿ä¸ªé£é©ãå®ä»¬æè®¸ææï¼æè®¸æèé£é©ï¼ä¹å¯è½ä¸¤è çæ ãä½ä¸ºä»ä¹è¦ç¨èªå·±çèº«ä½åå¥åº·å»åè¿ä¹å¤§çé£é©ï¼â\nããä»è¡¥å éï¼âå½ç¶ï¼æä¸å¦è®¤æªæ¥é¨åå¤è½ååçåºç±è¯ä¼å®æè§èæµè¯ï¼èµ°å® FDA ä»¥ååé¡¹çç®¡æµç¨ãå¦æç¡®å®åå¨å¸åºéæ±ï¼é£å°±å¼å±è¯éªï¼æ¨åºå®å ¨åè§ççæ¬ï¼èä¸æ¯æ¿äººèº«å®å ¨å»èµåãâ\nããåç¤¾äº¤åªä½é£æ½®ãåéè¯ç©èµ°çº¢å¸¦å¨ï¼ä¸»æçç©é»å®¢ä¸å »çåæçå¤è½ï¼ä¾å¦ BPCâ157ãTBâ500ï¼å¸åºç«çãä¸å°æ¶è´¹è å¯å¸æäºå®ä»¬å®ç°æè¡°èãæä¼¤ä¿®å¤ãå¢èçææã\nããæ¤å FDA å°å¤§éæªè·æ¹å¤è½åå ¥ç®¡æ§æ¸ åï¼ç¦æ¢è¯æ¿èªè¡è°é ãäºæ¯æ°ç¾ä¸ç¨æ·è½¬åå®å ¨æ²¡æçç®¡çé»å¸ä¸ç°å¸æ¸ éã\nããé¢å¯¹ç°ç¶ï¼ç¾å½å«çä¸å ¬ä¼æå¡é¨é¨é¿ç½ä¼¯ç¹ã»è¯å°¼è¿ªäºä¸èªç§°æ¯å¤è½çå¿ å®ä½¿ç¨è ï¼ä»æ¨å¨éå¤§æ¿çè½¬åï¼ææ¤é FDA å¯¹çº¦ 14 ç§çé¨å¤è½çéå¶ã\nããè¯å°¼è¿ªè®¤ä¸ºï¼æ¤åççç®¡ç¦ä»¤æ¬èº«å¹¶ä¸åæ³ï¼åèå¬çäºå±é©çå°ä¸å¸åºï¼éæ°å½ç±»ãå è®¸æ£è§è¯æ¿åè§è°é ï¼æå¯ä»¥è®©æ°ä¼è·å¾åçç®¡çäº§åã\nããææ¯è¾¾å°äº 2025 å¹´ 8 æåºä»»è¯ºåè¯ºå¾· CEOï¼æ¥æ¿ä»»èå¤å¹´çææ¯ã»å¼é²é«ã»çº¦æ ¹æ£®ã1992 å¹´ä»å¨ç»´ä¹çº³ä»¥æ®éåå ¬å®¤æåèº«ä»½å ¥èè¯ºåè¯ºå¾·ï¼åç» 33 å¹´æåï¼æç»æ§æè¿å®¶å·¨å¤´ã\nãã2015 å¹´ä»åä»»å½é ä¸å¡æ§è¡å¯æ»è£ï¼å ¨é¢æç®¡ç¾å½ä»¥å¤å ¨é¨åä¸çå¾ï¼å¸¦é¢è¯¥æ¿åå®ç°éå®é¢ç¿»åã\nããå¦ä»ï¼ææ¯è¾¾å°æèµè¿å®¶å»çå·¨å¤´ï¼ç´é¢ GLPâ1 èµéæ¿çç«äºï¼ä¸»è¦å¯¹æä¸ºç¤¼æ¥\nããææ¯è¾¾å°è¡¨ç¤ºï¼ä¸æ¹é¢è¦ä¼å Wegovy è¥éï¼åæ¶ç»§ç»æ¨å¨å£æç Wegovy æ¾éï¼ä¸å£åº¦å£æçäº§åä¸ç»©ä¸ååæå¸é¢æãå¦å¤ï¼ä»æ£å å¤§ç åæå ¥ï¼åºå¯¹æªæ¥æ°å¹´å¤æ¬¾ä¸å©å°æçææã\nããä¸è¿°ä¸¾æªè½å¦è½å°ï¼å¯¹ä¿®å¤è¯ºåè¯ºå¾·å¨åå°è¡ç¼ä¸çå½¢è±¡è³å ³éè¦ã\nããè¿å»ä¸å¹´ï¼è¯ºåè¯ºå¾·è¡ä»·ç´¯è®¡ä¸è· 17%ï¼åææ æ® 500 ææ°ä¸æ¶¨ 19%ï¼ç¤¼æ¥è¡ä»·å¤§æ¶¨ 57%ã\nããé«ç\nè´£ä»»ç¼è¾ï¼éæç \nVIPè¯¾ç¨æ¨è\nAPPä¸äº«ç´æ\nçé¨æ¨è\næ¶èµ·24å°æ¶æ»å¨ææ¥ææ°çè´¢ç»èµè®¯åè§é¢ï¼æ´å¤ç²ä¸ç¦å©æ«æäºç»´ç å ³æ³¨ï¼sinafinanceï¼","extraction":{"state":"ok","confidence":0.9,"error":null,"explanation":"High confidence: full text extraction produced 2228 characters.","diagnostics_url":"/api/diagnose?url=https%3A//finance.sina.com.cn/stock/usstock/c/2026-09-08/doc-inircrnn9212070.shtml%3Ffinpagefr%3Dp_108","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 2228 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":2228,"summary_length":2228,"usable_text_length":2228,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":2228,"summary_length":2228}}},"display_formats":["compact","card","full","digest_section","json"]},"daily_stack_record":{"title":"诺和诺德CEO：尚未对多肽热潮表示认同 - 新浪财经","url":"https://finance.sina.com.cn/stock/usstock/c/2026-09-08/doc-inircrnn9212070.shtml?finpagefr=p_108","summary":"ããè¯ºåè¯ºå¾·\nããä½å¯¹äºå¤è½é¢åå°ä¸å¸åºçä¹±è±¡ï¼ä»å´æåº¦å·æ·¡ãä¸å°ç½çº¢åä¸»è´ä¹°æªç»æ£éªçå¤è½éåç¨æ¥æ¹åç®è¤ç¶æï¼å¥èº«ç±å¥½è ä¹ä¹°æ¥è¿ç±»äº§åï¼å¸æå¿«éåèã\nããææ¯è¾¾å°å¨ãä¸çå¤§åè®¿è°ãææ°ä¸ææå®¢èç®ä¸è¡¨ç¤ºï¼âå¸é¢ä¸æå¤§éè¿ç±»å¤è½äº§åï¼å®ä»¬ä¸å Wegovy çåãä¹ä¸åæä»¬çè°å²ç´ ï¼å®å ¨æ²¡æç»è¿éªè¯ãå å ¶éåªåè¿é¨åå¨ç©å®éªï¼åªè§å¯è¿å¨å¤§é¼ ãå°é¼ èº«ä¸çååºï¼æ ¹æ¬æ²¡æå¼å±äººä½ä¸´åºè¯éªãå»è¯è¡ä¸çç®¡ååå¿ è¦ï¼å ä¸ºè¯ç©ä¼äº§çä¸¥éå¯ä½ç¨ãè¦ç¥éï¼è¯¯ç¨è¯ç©æ¯ä¼è´äººæ»äº¡çãè¿å¯ä¸æ¯ä¹°ä¸ªé«ä»¿å¤é©°å é£ä¹ç®åï¼ä¼å¸¦æ¥å®å®å¨å¨çä¸¥éåæãâ\nããææ¯è¾¾å°è®¤ä¸ºï¼ç¾å½é£åè¯åçç£ç®¡çå±ï¼FDAï¼åºå½å¯¹è¿ç±»å¤è½å®æ½çç®¡ã\nããâè¿äºäº§åæ²¡æç»è¿éªè¯ï¼æä»¥æççæ¡æ¯ï¼æä¸ç¥éå®ä»¬å®ä¸å®å ¨ãæèªå·±ç»å¯¹ä¸ä¼å»åè¿ä¸ªé£é©ãå®ä»¬æè®¸ææï¼æè®¸æèé£é©ï¼ä¹å¯è½ä¸¤è çæ ãä½ä¸ºä»ä¹è¦ç¨èªå·±çèº«ä½åå¥åº·å»åè¿ä¹å¤§çé£é©ï¼â\nããä»è¡¥å éï¼âå½ç¶ï¼æä¸å¦è®¤æªæ¥é¨åå¤è½ååçåºç±è¯ä¼å®æè§èæµè¯ï¼èµ°å® FDA ä»¥ååé¡¹çç®¡æµç¨ãå¦æç¡®å®åå¨å¸åºéæ±ï¼é£å°±å¼å±è¯éªï¼æ¨åºå®å ¨åè§ççæ¬ï¼èä¸æ¯æ¿äººèº«å®å ¨å»èµåãâ\nããåç¤¾äº¤åªä½é£æ½®ãåéè¯ç©èµ°çº¢å¸¦å¨ï¼ä¸»æçç©é»å®¢ä¸å »çåæçå¤è½ï¼ä¾å¦ BPCâ157ãTBâ500ï¼å¸åºç«çãä¸å°æ¶è´¹è å¯å¸æäºå®ä»¬å®ç°æè¡°èãæä¼¤ä¿®å¤ãå¢èçææã\nããæ¤å FDA å°å¤§éæªè·æ¹å¤è½åå ¥ç®¡æ§æ¸ åï¼ç¦æ¢è¯æ¿èªè¡è°é ãäºæ¯æ°ç¾ä¸ç¨æ·è½¬åå®å ¨æ²¡æçç®¡çé»å¸ä¸ç°å¸æ¸ éã\nããé¢å¯¹ç°ç¶ï¼ç¾å½å«çä¸å ¬ä¼æå¡é¨é¨é¿ç½ä¼¯ç¹ã»è¯å°¼è¿ªäºä¸èªç§°æ¯å¤è½çå¿ å®ä½¿ç¨è ï¼ä»æ¨å¨éå¤§æ¿çè½¬åï¼ææ¤é FDA å¯¹çº¦ 14 ç§çé¨å¤è½çéå¶ã\nããè¯å°¼è¿ªè®¤ä¸ºï¼æ¤åççç®¡ç¦ä»¤æ¬èº«å¹¶ä¸åæ³ï¼åèå¬çäºå±é©çå°ä¸å¸åºï¼éæ°å½ç±»ãå è®¸æ£è§è¯æ¿åè§è°é ï¼æå¯ä»¥è®©æ°ä¼è·å¾åçç®¡çäº§åã\nããææ¯è¾¾å°äº 2025 å¹´ 8 æåºä»»è¯ºåè¯ºå¾· CEOï¼æ¥æ¿ä»»èå¤å¹´çææ¯ã»å¼é²é«ã»çº¦æ ¹æ£®ã1992 å¹´ä»å¨ç»´ä¹çº³ä»¥æ®éåå ¬å®¤æåèº«ä»½å ¥èè¯ºåè¯ºå¾·ï¼åç» 33 å¹´æåï¼æç»æ§æè¿å®¶å·¨å¤´ã\nãã2015 å¹´ä»åä»»å½é ä¸å¡æ§è¡å¯æ»è£ï¼å ¨é¢æç®¡ç¾å½ä»¥å¤å ¨é¨åä¸çå¾ï¼å¸¦é¢è¯¥æ¿åå®ç°éå®é¢ç¿»åã\nããå¦ä»ï¼ææ¯è¾¾å°æèµè¿å®¶å»çå·¨å¤´ï¼ç´é¢ GLPâ1 èµéæ¿çç«äºï¼ä¸»è¦å¯¹æä¸ºç¤¼æ¥\nããææ¯è¾¾å°è¡¨ç¤ºï¼ä¸æ¹é¢è¦ä¼å Wegovy è¥éï¼åæ¶ç»§ç»æ¨å¨å£æç Wegovy æ¾éï¼ä¸å£åº¦å£æçäº§åä¸ç»©ä¸ååæå¸é¢æãå¦å¤ï¼ä»æ£å å¤§ç åæå ¥ï¼åºå¯¹æªæ¥æ°å¹´å¤æ¬¾ä¸å©å°æçææã\nããä¸è¿°ä¸¾æªè½å¦è½å°ï¼å¯¹ä¿®å¤è¯ºåè¯ºå¾·å¨åå°è¡ç¼ä¸çå½¢è±¡è³å ³éè¦ã\nããè¿å»ä¸å¹´ï¼è¯ºåè¯ºå¾·è¡ä»·ç´¯è®¡ä¸è· 17%ï¼åææ æ® 500 ææ°ä¸æ¶¨ 19%ï¼ç¤¼æ¥è¡ä»·å¤§æ¶¨ 57%ã\nããé«ç\nè´£ä»»ç¼è¾ï¼éæç \nVIPè¯¾ç¨æ¨è\nAPPä¸äº«ç´æ\nçé¨æ¨è\næ¶èµ·24å°æ¶æ»å¨ææ¥ææ°çè´¢ç»èµè®¯åè§é¢ï¼æ´å¤ç²ä¸ç¦å©æ«æäºç»´ç å ³æ³¨ï¼sinafinanceï¼","source":"新浪财经","date":"2026-09-08T07:00:00+00:00","content":"ããè¯ºåè¯ºå¾·\nããä½å¯¹äºå¤è½é¢åå°ä¸å¸åºçä¹±è±¡ï¼ä»å´æåº¦å·æ·¡ãä¸å°ç½çº¢åä¸»è´ä¹°æªç»æ£éªçå¤è½éåç¨æ¥æ¹åç®è¤ç¶æï¼å¥èº«ç±å¥½è ä¹ä¹°æ¥è¿ç±»äº§åï¼å¸æå¿«éåèã\nããææ¯è¾¾å°å¨ãä¸çå¤§åè®¿è°ãææ°ä¸ææå®¢èç®ä¸è¡¨ç¤ºï¼âå¸é¢ä¸æå¤§éè¿ç±»å¤è½äº§åï¼å®ä»¬ä¸å Wegovy çåãä¹ä¸åæä»¬çè°å²ç´ ï¼å®å ¨æ²¡æç»è¿éªè¯ãå å ¶éåªåè¿é¨åå¨ç©å®éªï¼åªè§å¯è¿å¨å¤§é¼ ãå°é¼ èº«ä¸çååºï¼æ ¹æ¬æ²¡æå¼å±äººä½ä¸´åºè¯éªãå»è¯è¡ä¸çç®¡ååå¿ è¦ï¼å ä¸ºè¯ç©ä¼äº§çä¸¥éå¯ä½ç¨ãè¦ç¥éï¼è¯¯ç¨è¯ç©æ¯ä¼è´äººæ»äº¡çãè¿å¯ä¸æ¯ä¹°ä¸ªé«ä»¿å¤é©°å é£ä¹ç®åï¼ä¼å¸¦æ¥å®å®å¨å¨çä¸¥éåæãâ\nããææ¯è¾¾å°è®¤ä¸ºï¼ç¾å½é£åè¯åçç£ç®¡çå±ï¼FDAï¼åºå½å¯¹è¿ç±»å¤è½å®æ½çç®¡ã\nããâè¿äºäº§åæ²¡æç»è¿éªè¯ï¼æä»¥æççæ¡æ¯ï¼æä¸ç¥éå®ä»¬å®ä¸å®å ¨ãæèªå·±ç»å¯¹ä¸ä¼å»åè¿ä¸ªé£é©ãå®ä»¬æè®¸ææï¼æè®¸æèé£é©ï¼ä¹å¯è½ä¸¤è çæ ãä½ä¸ºä»ä¹è¦ç¨èªå·±çèº«ä½åå¥åº·å»åè¿ä¹å¤§çé£é©ï¼â\nããä»è¡¥å éï¼âå½ç¶ï¼æä¸å¦è®¤æªæ¥é¨åå¤è½ååçåºç±è¯ä¼å®æè§èæµè¯ï¼èµ°å® FDA ä»¥ååé¡¹çç®¡æµç¨ãå¦æç¡®å®åå¨å¸åºéæ±ï¼é£å°±å¼å±è¯éªï¼æ¨åºå®å ¨åè§ççæ¬ï¼èä¸æ¯æ¿äººèº«å®å ¨å»èµåãâ\nããåç¤¾äº¤åªä½é£æ½®ãåéè¯ç©èµ°çº¢å¸¦å¨ï¼ä¸»æçç©é»å®¢ä¸å »çåæçå¤è½ï¼ä¾å¦ BPCâ157ãTBâ500ï¼å¸åºç«çãä¸å°æ¶è´¹è å¯å¸æäºå®ä»¬å®ç°æè¡°èãæä¼¤ä¿®å¤ãå¢èçææã\nããæ¤å FDA å°å¤§éæªè·æ¹å¤è½åå ¥ç®¡æ§æ¸ åï¼ç¦æ¢è¯æ¿èªè¡è°é ãäºæ¯æ°ç¾ä¸ç¨æ·è½¬åå®å ¨æ²¡æçç®¡çé»å¸ä¸ç°å¸æ¸ éã\nããé¢å¯¹ç°ç¶ï¼ç¾å½å«çä¸å ¬ä¼æå¡é¨é¨é¿ç½ä¼¯ç¹ã»è¯å°¼è¿ªäºä¸èªç§°æ¯å¤è½çå¿ å®ä½¿ç¨è ï¼ä»æ¨å¨éå¤§æ¿çè½¬åï¼ææ¤é FDA å¯¹çº¦ 14 ç§çé¨å¤è½çéå¶ã\nããè¯å°¼è¿ªè®¤ä¸ºï¼æ¤åççç®¡ç¦ä»¤æ¬èº«å¹¶ä¸åæ³ï¼åèå¬çäºå±é©çå°ä¸å¸åºï¼éæ°å½ç±»ãå è®¸æ£è§è¯æ¿åè§è°é ï¼æå¯ä»¥è®©æ°ä¼è·å¾åçç®¡çäº§åã\nããææ¯è¾¾å°äº 2025 å¹´ 8 æåºä»»è¯ºåè¯ºå¾· CEOï¼æ¥æ¿ä»»èå¤å¹´çææ¯ã»å¼é²é«ã»çº¦æ ¹æ£®ã1992 å¹´ä»å¨ç»´ä¹çº³ä»¥æ®éåå ¬å®¤æåèº«ä»½å ¥èè¯ºåè¯ºå¾·ï¼åç» 33 å¹´æåï¼æç»æ§æè¿å®¶å·¨å¤´ã\nãã2015 å¹´ä»åä»»å½é ä¸å¡æ§è¡å¯æ»è£ï¼å ¨é¢æç®¡ç¾å½ä»¥å¤å ¨é¨åä¸çå¾ï¼å¸¦é¢è¯¥æ¿åå®ç°éå®é¢ç¿»åã\nããå¦ä»ï¼ææ¯è¾¾å°æèµè¿å®¶å»çå·¨å¤´ï¼ç´é¢ GLPâ1 èµéæ¿çç«äºï¼ä¸»è¦å¯¹æä¸ºç¤¼æ¥\nããææ¯è¾¾å°è¡¨ç¤ºï¼ä¸æ¹é¢è¦ä¼å Wegovy è¥éï¼åæ¶ç»§ç»æ¨å¨å£æç Wegovy æ¾éï¼ä¸å£åº¦å£æçäº§åä¸ç»©ä¸ååæå¸é¢æãå¦å¤ï¼ä»æ£å å¤§ç åæå ¥ï¼åºå¯¹æªæ¥æ°å¹´å¤æ¬¾ä¸å©å°æçææã\nããä¸è¿°ä¸¾æªè½å¦è½å°ï¼å¯¹ä¿®å¤è¯ºåè¯ºå¾·å¨åå°è¡ç¼ä¸çå½¢è±¡è³å ³éè¦ã\nããè¿å»ä¸å¹´ï¼è¯ºåè¯ºå¾·è¡ä»·ç´¯è®¡ä¸è· 17%ï¼åææ æ® 500 ææ°ä¸æ¶¨ 19%ï¼ç¤¼æ¥è¡ä»·å¤§æ¶¨ 57%ã\nããé«ç\nè´£ä»»ç¼è¾ï¼éæç \nVIPè¯¾ç¨æ¨è\nAPPä¸äº«ç´æ\nçé¨æ¨è\næ¶èµ·24å°æ¶æ»å¨ææ¥ææ°çè´¢ç»èµè®¯åè§é¢ï¼æ´å¤ç²ä¸ç¦å©æ«æäºç»´ç å ³æ³¨ï¼sinafinanceï¼","confidence":0.9,"diagnostics_url":"/api/diagnose?url=https%3A//finance.sina.com.cn/stock/usstock/c/2026-09-08/doc-inircrnn9212070.shtml%3Ffinpagefr%3Dp_108","quality_bucket":"high","failure_kind":"none","retryable":false,"quality_reason":"High confidence: full text extraction produced 2228 characters.","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 2228 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":2228,"summary_length":2228,"usable_text_length":2228,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":2228,"summary_length":2228}},"tags":[]},"fallback_formats":["markdown","json","html"],"actions":{"read":"/item/93897","export_markdown":"/api/items/93897/export?format=markdown","export_json":"/api/items/93897/export?format=json","diagnose":"/api/diagnose?url=https%3A//finance.sina.com.cn/stock/usstock/c/2026-09-08/doc-inircrnn9212070.shtml%3Ffinpagefr%3Dp_108"},"formats":{"full":{"id":93897,"title":"诺和诺德CEO：尚未对多肽热潮表示认同 - 新浪财经","url":"https://finance.sina.com.cn/stock/usstock/c/2026-09-08/doc-inircrnn9212070.shtml?finpagefr=p_108","source":"新浪财经","author":null,"published_at":"2026-09-08T07:00:00+00:00","locale":"zh","topic":"peptides","tags":[],"excerpt":"ããè¯ºåè¯ºå¾·\nããä½å¯¹äºå¤è½é¢åå°ä¸å¸åºçä¹±è±¡ï¼ä»å´æåº¦å·æ·¡ãä¸å°ç½çº¢åä¸»è´ä¹°æªç»æ£éªçå¤è½éåç¨æ¥æ¹åç®è¤ç¶æï¼å¥èº«ç±å¥½è ä¹ä¹°æ¥è¿ç±»äº§åï¼å¸æå¿«éåèã\nããææ¯è¾¾å°å¨ãä¸çå¤§åè®¿è°ãææ°ä¸ææå®¢èç®ä¸è¡¨ç¤ºï¼âå¸é¢ä¸æå¤§éè¿ç±»å¤è½äº§åï¼å®ä»¬ä¸å Wegovy çåãä¹ä¸åæä»¬çè°å²ç´ ï¼å®å ¨æ²¡æç»è¿éªè¯ãå å ¶éåªåè¿é¨åå¨ç©å®éªï¼åªè§å¯è¿å¨å¤§é¼ ãå°é¼ èº«ä¸çååºï¼æ ¹æ¬æ²¡æå¼å±äººä½ä¸´åºè¯éªãå»è¯è¡ä¸çç®¡ååå¿ è¦ï¼å ä¸ºè¯ç©ä¼äº§çä¸¥éå¯ä½ç¨ãè¦ç¥éï¼è¯¯ç¨è¯ç©æ¯ä¼è´äººæ»äº¡çãè¿å¯ä¸æ¯ä¹°ä¸ªé«ä»¿å¤é©°å é£ä¹ç®åï¼ä¼å¸¦æ¥å®å®å¨å¨çä¸¥éåæãâ\nããææ¯è¾¾å°è®¤ä¸ºï¼ç¾å½é£åè¯åçç£ç®¡çå±ï¼FDAï¼åºå½å¯¹è¿ç±»å¤è½å®æ½çç®¡ã\nããâè¿äºäº§åæ²¡æç»è¿éªè¯ï¼æä»¥æççæ¡æ¯ï¼æä¸ç¥éå®ä»¬å®ä¸å®å ¨ãæèªå·±ç»å¯¹ä¸ä¼å»åè¿ä¸ªé£é©ãå®ä»¬æè®¸ææï¼æè®¸æèé£é©ï¼ä¹å¯è½ä¸¤è çæ ãä½ä¸ºä»ä¹è¦ç¨èªå·±çèº«ä½åå¥åº·å»åè¿ä¹å¤§çé£é©ï¼â\nããä»è¡¥å éï¼âå½ç¶ï¼æä¸å¦è®¤æªæ¥é¨åå¤è½ååçåºç±è¯ä¼å®æè§èæµè¯ï¼èµ°å® FDA ä»¥ååé¡¹çç®¡æµç¨ãå¦æç¡®å®åå¨å¸åºéæ±ï¼é£å°±å¼å±è¯éªï¼æ¨åºå®å ¨åè§ççæ¬ï¼èä¸æ¯æ¿äººèº«å®å ¨å»èµåãâ\nããåç¤¾äº¤åªä½é£æ½®ãåéè¯ç©èµ°çº¢å¸¦å¨ï¼ä¸»æçç©é»å®¢ä¸å »çåæçå¤è½ï¼ä¾å¦ BPCâ157ãTBâ500ï¼å¸åºç«çãä¸å°æ¶è´¹è å¯å¸æäºå®ä»¬å®ç°æè¡°èãæä¼¤ä¿®å¤ãå¢èçææã\nããæ¤å FDA å°å¤§éæªè·æ¹å¤è½åå ¥ç®¡æ§æ¸ åï¼ç¦æ¢è¯æ¿èªè¡è°é ãäºæ¯æ°ç¾ä¸ç¨æ·è½¬åå®å ¨æ²¡æçç®¡çé»å¸ä¸ç°å¸æ¸ éã\nããé¢å¯¹ç°ç¶ï¼ç¾å½å«çä¸å ¬ä¼æå¡é¨é¨é¿ç½ä¼¯ç¹ã»è¯å°¼è¿ªäºä¸èªç§°æ¯å¤è½çå¿ å®ä½¿ç¨è ï¼ä»æ¨å¨éå¤§æ¿çè½¬åï¼ææ¤é FDA å¯¹çº¦ 14 ç§çé¨å¤è½çéå¶ã\nããè¯å°¼è¿ªè®¤ä¸ºï¼æ¤åççç®¡ç¦ä»¤æ¬èº«å¹¶ä¸åæ³ï¼åèå¬çäºå±é©çå°ä¸å¸åºï¼éæ°å½ç±»ãå è®¸æ£è§è¯æ¿åè§è°é ï¼æå¯ä»¥è®©æ°ä¼è·å¾åçç®¡çäº§åã\nããææ¯è¾¾å°äº 2025 å¹´ 8 æåºä»»è¯ºåè¯ºå¾· CEOï¼æ¥æ¿ä»»èå¤å¹´çææ¯ã»å¼é²é«ã»çº¦æ ¹æ£®ã1992 å¹´ä»å¨ç»´ä¹çº³ä»¥æ®éåå ¬å®¤æåèº«ä»½å ¥èè¯ºåè¯ºå¾·ï¼åç» 33 å¹´æåï¼æç»æ§æè¿å®¶å·¨å¤´ã\nãã2015 å¹´ä»åä»»å½é ä¸å¡æ§è¡å¯æ»è£ï¼å ¨é¢æç®¡ç¾å½ä»¥å¤å ¨é¨åä¸çå¾ï¼å¸¦é¢è¯¥æ¿åå®ç°éå®é¢ç¿»åã\nããå¦ä»ï¼ææ¯è¾¾å°æèµè¿å®¶å»çå·¨å¤´ï¼ç´é¢ GLPâ1 èµéæ¿çç«äºï¼ä¸»è¦å¯¹æä¸ºç¤¼æ¥\nããææ¯è¾¾å°è¡¨ç¤ºï¼ä¸æ¹é¢è¦ä¼å Wegovy è¥éï¼åæ¶ç»§ç»æ¨å¨å£æç Wegovy æ¾éï¼ä¸å£åº¦å£æçäº§åä¸ç»©ä¸ååæå¸é¢æãå¦å¤ï¼ä»æ£å å¤§ç åæå ¥ï¼åºå¯¹æªæ¥æ°å¹´å¤æ¬¾ä¸å©å°æçææã\nããä¸è¿°ä¸¾æªè½å¦è½å°ï¼å¯¹ä¿®å¤è¯ºåè¯ºå¾·å¨åå°è¡ç¼ä¸çå½¢è±¡è³å ³éè¦ã\nããè¿å»ä¸å¹´ï¼è¯ºåè¯ºå¾·è¡ä»·ç´¯è®¡ä¸è· 17%ï¼åææ æ® 500 ææ°ä¸æ¶¨ 19%ï¼ç¤¼æ¥è¡ä»·å¤§æ¶¨ 57%ã\nããé«ç\nè´£ä»»ç¼è¾ï¼éæç \nVIPè¯¾ç¨æ¨è\nAPPä¸äº«ç´æ\nçé¨æ¨è\næ¶èµ·24å°æ¶æ»å¨ææ¥ææ°çè´¢ç»èµè®¯åè§é¢ï¼æ´å¤ç²ä¸ç¦å©æ«æäºç»´ç å ³æ³¨ï¼sinafinanceï¼","full_text":"ããè¯ºåè¯ºå¾·\nããä½å¯¹äºå¤è½é¢åå°ä¸å¸åºçä¹±è±¡ï¼ä»å´æåº¦å·æ·¡ãä¸å°ç½çº¢åä¸»è´ä¹°æªç»æ£éªçå¤è½éåç¨æ¥æ¹åç®è¤ç¶æï¼å¥èº«ç±å¥½è ä¹ä¹°æ¥è¿ç±»äº§åï¼å¸æå¿«éåèã\nããææ¯è¾¾å°å¨ãä¸çå¤§åè®¿è°ãææ°ä¸ææå®¢èç®ä¸è¡¨ç¤ºï¼âå¸é¢ä¸æå¤§éè¿ç±»å¤è½äº§åï¼å®ä»¬ä¸å Wegovy çåãä¹ä¸åæä»¬çè°å²ç´ ï¼å®å ¨æ²¡æç»è¿éªè¯ãå å ¶éåªåè¿é¨åå¨ç©å®éªï¼åªè§å¯è¿å¨å¤§é¼ ãå°é¼ èº«ä¸çååºï¼æ ¹æ¬æ²¡æå¼å±äººä½ä¸´åºè¯éªãå»è¯è¡ä¸çç®¡ååå¿ è¦ï¼å ä¸ºè¯ç©ä¼äº§çä¸¥éå¯ä½ç¨ãè¦ç¥éï¼è¯¯ç¨è¯ç©æ¯ä¼è´äººæ»äº¡çãè¿å¯ä¸æ¯ä¹°ä¸ªé«ä»¿å¤é©°å é£ä¹ç®åï¼ä¼å¸¦æ¥å®å®å¨å¨çä¸¥éåæãâ\nããææ¯è¾¾å°è®¤ä¸ºï¼ç¾å½é£åè¯åçç£ç®¡çå±ï¼FDAï¼åºå½å¯¹è¿ç±»å¤è½å®æ½çç®¡ã\nããâè¿äºäº§åæ²¡æç»è¿éªè¯ï¼æä»¥æççæ¡æ¯ï¼æä¸ç¥éå®ä»¬å®ä¸å®å ¨ãæèªå·±ç»å¯¹ä¸ä¼å»åè¿ä¸ªé£é©ãå®ä»¬æè®¸ææï¼æè®¸æèé£é©ï¼ä¹å¯è½ä¸¤è çæ ãä½ä¸ºä»ä¹è¦ç¨èªå·±çèº«ä½åå¥åº·å»åè¿ä¹å¤§çé£é©ï¼â\nããä»è¡¥å éï¼âå½ç¶ï¼æä¸å¦è®¤æªæ¥é¨åå¤è½ååçåºç±è¯ä¼å®æè§èæµè¯ï¼èµ°å® FDA ä»¥ååé¡¹çç®¡æµç¨ãå¦æç¡®å®åå¨å¸åºéæ±ï¼é£å°±å¼å±è¯éªï¼æ¨åºå®å ¨åè§ççæ¬ï¼èä¸æ¯æ¿äººèº«å®å ¨å»èµåãâ\nããåç¤¾äº¤åªä½é£æ½®ãåéè¯ç©èµ°çº¢å¸¦å¨ï¼ä¸»æçç©é»å®¢ä¸å »çåæçå¤è½ï¼ä¾å¦ BPCâ157ãTBâ500ï¼å¸åºç«çãä¸å°æ¶è´¹è å¯å¸æäºå®ä»¬å®ç°æè¡°èãæä¼¤ä¿®å¤ãå¢èçææã\nããæ¤å FDA å°å¤§éæªè·æ¹å¤è½åå ¥ç®¡æ§æ¸ åï¼ç¦æ¢è¯æ¿èªè¡è°é ãäºæ¯æ°ç¾ä¸ç¨æ·è½¬åå®å ¨æ²¡æçç®¡çé»å¸ä¸ç°å¸æ¸ éã\nããé¢å¯¹ç°ç¶ï¼ç¾å½å«çä¸å ¬ä¼æå¡é¨é¨é¿ç½ä¼¯ç¹ã»è¯å°¼è¿ªäºä¸èªç§°æ¯å¤è½çå¿ å®ä½¿ç¨è ï¼ä»æ¨å¨éå¤§æ¿çè½¬åï¼ææ¤é FDA å¯¹çº¦ 14 ç§çé¨å¤è½çéå¶ã\nããè¯å°¼è¿ªè®¤ä¸ºï¼æ¤åççç®¡ç¦ä»¤æ¬èº«å¹¶ä¸åæ³ï¼åèå¬çäºå±é©çå°ä¸å¸åºï¼éæ°å½ç±»ãå è®¸æ£è§è¯æ¿åè§è°é ï¼æå¯ä»¥è®©æ°ä¼è·å¾åçç®¡çäº§åã\nããææ¯è¾¾å°äº 2025 å¹´ 8 æåºä»»è¯ºåè¯ºå¾· CEOï¼æ¥æ¿ä»»èå¤å¹´çææ¯ã»å¼é²é«ã»çº¦æ ¹æ£®ã1992 å¹´ä»å¨ç»´ä¹çº³ä»¥æ®éåå ¬å®¤æåèº«ä»½å ¥èè¯ºåè¯ºå¾·ï¼åç» 33 å¹´æåï¼æç»æ§æè¿å®¶å·¨å¤´ã\nãã2015 å¹´ä»åä»»å½é ä¸å¡æ§è¡å¯æ»è£ï¼å ¨é¢æç®¡ç¾å½ä»¥å¤å ¨é¨åä¸çå¾ï¼å¸¦é¢è¯¥æ¿åå®ç°éå®é¢ç¿»åã\nããå¦ä»ï¼ææ¯è¾¾å°æèµè¿å®¶å»çå·¨å¤´ï¼ç´é¢ GLPâ1 èµéæ¿çç«äºï¼ä¸»è¦å¯¹æä¸ºç¤¼æ¥\nããææ¯è¾¾å°è¡¨ç¤ºï¼ä¸æ¹é¢è¦ä¼å Wegovy è¥éï¼åæ¶ç»§ç»æ¨å¨å£æç Wegovy æ¾éï¼ä¸å£åº¦å£æçäº§åä¸ç»©ä¸ååæå¸é¢æãå¦å¤ï¼ä»æ£å å¤§ç åæå ¥ï¼åºå¯¹æªæ¥æ°å¹´å¤æ¬¾ä¸å©å°æçææã\nããä¸è¿°ä¸¾æªè½å¦è½å°ï¼å¯¹ä¿®å¤è¯ºåè¯ºå¾·å¨åå°è¡ç¼ä¸çå½¢è±¡è³å ³éè¦ã\nããè¿å»ä¸å¹´ï¼è¯ºåè¯ºå¾·è¡ä»·ç´¯è®¡ä¸è· 17%ï¼åææ æ® 500 ææ°ä¸æ¶¨ 19%ï¼ç¤¼æ¥è¡ä»·å¤§æ¶¨ 57%ã\nããé«ç\nè´£ä»»ç¼è¾ï¼éæç \nVIPè¯¾ç¨æ¨è\nAPPä¸äº«ç´æ\nçé¨æ¨è\næ¶èµ·24å°æ¶æ»å¨ææ¥ææ°çè´¢ç»èµè®¯åè§é¢ï¼æ´å¤ç²ä¸ç¦å©æ«æäºç»´ç å ³æ³¨ï¼sinafinanceï¼","reading_time_min":1,"extraction":{"state":"ok","confidence":0.9,"error":null,"explanation":"High confidence: full text extraction produced 2228 characters.","diagnostics_url":"/api/diagnose?url=https%3A//finance.sina.com.cn/stock/usstock/c/2026-09-08/doc-inircrnn9212070.shtml%3Ffinpagefr%3Dp_108","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 2228 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":2228,"summary_length":2228,"usable_text_length":2228,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":2228,"summary_length":2228}}},"quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 2228 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":2228,"summary_length":2228,"usable_text_length":2228,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":2228,"summary_length":2228}},"actions":{"read":"/item/93897","export_markdown":"/api/items/93897/export?format=markdown","export_json":"/api/items/93897/export?format=json","diagnose":"/api/diagnose?url=https%3A//finance.sina.com.cn/stock/usstock/c/2026-09-08/doc-inircrnn9212070.shtml%3Ffinpagefr%3Dp_108"}},"digest":{"id":93897,"title":"诺和诺德CEO：尚未对多肽热潮表示认同 - 新浪财经","url":"https://finance.sina.com.cn/stock/usstock/c/2026-09-08/doc-inircrnn9212070.shtml?finpagefr=p_108","source":"新浪财经","topic":"peptides","published_at":"2026-09-08T07:00:00+00:00","excerpt":"ããè¯ºåè¯ºå¾· ããä½å¯¹äºå¤è½é¢åå°ä¸å¸åºçä¹±è±¡ï¼ä»å´æåº¦å·æ·¡ãä¸å°ç½çº¢åä¸»è´ä¹°æªç»æ£éªçå¤è½éåç¨æ¥æ¹åç®è¤ç¶æï¼å¥èº«ç±å¥½è ä¹ä¹°æ¥è¿ç±»äº§åï¼å¸æå¿«éåèã ããææ¯è¾¾å°å¨ãä¸çå¤§åè®¿è°ãææ°ä¸ææå®¢èç®ä¸è¡¨ç¤ºï¼âå¸é¢ä¸æå¤§éè¿ç±»å¤è½äº§åï¼å®ä»¬ä¸å Wegovy çåãä¹ä¸åæä»¬çè°å²ç´ ï¼å®å…","quality_bucket":"high","quality_reason":"High confidence: full text extraction produced 2228 characters.","reading_time_min":1,"cluster_id":3538506},"card":{"display_title":"诺和诺德CEO：尚未对多肽热潮表示认同 - 新浪财经","subtitle":"新浪财经 · 2026-09-08","summary":"ããè¯ºåè¯ºå¾· ããä½å¯¹äºå¤è½é¢åå°ä¸å¸åºçä¹±è±¡ï¼ä»å´æåº¦å·æ·¡ãä¸å°ç½çº¢åä¸»è´ä¹°æªç»æ£éªçå¤è½éåç¨æ¥æ¹åç®è¤ç¶æï¼å¥èº«ç±å¥½è ä¹ä¹°æ¥è¿ç±»äº§åï¼å¸æå¿«éåèã…","badges":["quality:high"],"links":{"read":"/item/93897","original":"https://finance.sina.com.cn/stock/usstock/c/2026-09-08/doc-inircrnn9212070.shtml?finpagefr=p_108","diagnose":"/api/diagnose?url=https%3A//finance.sina.com.cn/stock/usstock/c/2026-09-08/doc-inircrnn9212070.shtml%3Ffinpagefr%3Dp_108"},"quality_warning":null},"export":{"title":"诺和诺德CEO：尚未对多肽热潮表示认同 - 新浪财经","url":"https://finance.sina.com.cn/stock/usstock/c/2026-09-08/doc-inircrnn9212070.shtml?finpagefr=p_108","summary":"ããè¯ºåè¯ºå¾·\nããä½å¯¹äºå¤è½é¢åå°ä¸å¸åºçä¹±è±¡ï¼ä»å´æåº¦å·æ·¡ãä¸å°ç½çº¢åä¸»è´ä¹°æªç»æ£éªçå¤è½éåç¨æ¥æ¹åç®è¤ç¶æï¼å¥èº«ç±å¥½è ä¹ä¹°æ¥è¿ç±»äº§åï¼å¸æå¿«éåèã\nããææ¯è¾¾å°å¨ãä¸çå¤§åè®¿è°ãææ°ä¸ææå®¢èç®ä¸è¡¨ç¤ºï¼âå¸é¢ä¸æå¤§éè¿ç±»å¤è½äº§åï¼å®ä»¬ä¸å Wegovy çåãä¹ä¸åæä»¬çè°å²ç´ ï¼å®å ¨æ²¡æç»è¿éªè¯ãå å ¶éåªåè¿é¨åå¨ç©å®éªï¼åªè§å¯è¿å¨å¤§é¼ ãå°é¼ èº«ä¸çååºï¼æ ¹æ¬æ²¡æå¼å±äººä½ä¸´åºè¯éªãå»è¯è¡ä¸çç®¡ååå¿ è¦ï¼å ä¸ºè¯ç©ä¼äº§çä¸¥éå¯ä½ç¨ãè¦ç¥éï¼è¯¯ç¨è¯ç©æ¯ä¼è´äººæ»äº¡çãè¿å¯ä¸æ¯ä¹°ä¸ªé«ä»¿å¤é©°å é£ä¹ç®åï¼ä¼å¸¦æ¥å®å®å¨å¨çä¸¥éåæãâ\nããææ¯è¾¾å°è®¤ä¸ºï¼ç¾å½é£åè¯åçç£ç®¡çå±ï¼FDAï¼åºå½å¯¹è¿ç±»å¤è½å®æ½çç®¡ã\nããâè¿äºäº§åæ²¡æç»è¿éªè¯ï¼æä»¥æççæ¡æ¯ï¼æä¸ç¥éå®ä»¬å®ä¸å®å ¨ãæèªå·±ç»å¯¹ä¸ä¼å»åè¿ä¸ªé£é©ãå®ä»¬æè®¸ææï¼æè®¸æèé£é©ï¼ä¹å¯è½ä¸¤è çæ ãä½ä¸ºä»ä¹è¦ç¨èªå·±çèº«ä½åå¥åº·å»åè¿ä¹å¤§çé£é©ï¼â\nããä»è¡¥å éï¼âå½ç¶ï¼æä¸å¦è®¤æªæ¥é¨åå¤è½ååçåºç±è¯ä¼å®æè§èæµè¯ï¼èµ°å® FDA ä»¥ååé¡¹çç®¡æµç¨ãå¦æç¡®å®åå¨å¸åºéæ±ï¼é£å°±å¼å±è¯éªï¼æ¨åºå®å ¨åè§ççæ¬ï¼èä¸æ¯æ¿äººèº«å®å ¨å»èµåãâ\nããåç¤¾äº¤åªä½é£æ½®ãåéè¯ç©èµ°çº¢å¸¦å¨ï¼ä¸»æçç©é»å®¢ä¸å »çåæçå¤è½ï¼ä¾å¦ BPCâ157ãTBâ500ï¼å¸åºç«çãä¸å°æ¶è´¹è å¯å¸æäºå®ä»¬å®ç°æè¡°èãæä¼¤ä¿®å¤ãå¢èçææã\nããæ¤å FDA å°å¤§éæªè·æ¹å¤è½åå ¥ç®¡æ§æ¸ åï¼ç¦æ¢è¯æ¿èªè¡è°é ãäºæ¯æ°ç¾ä¸ç¨æ·è½¬åå®å ¨æ²¡æçç®¡çé»å¸ä¸ç°å¸æ¸ éã\nããé¢å¯¹ç°ç¶ï¼ç¾å½å«çä¸å ¬ä¼æå¡é¨é¨é¿ç½ä¼¯ç¹ã»è¯å°¼è¿ªäºä¸èªç§°æ¯å¤è½çå¿ å®ä½¿ç¨è ï¼ä»æ¨å¨éå¤§æ¿çè½¬åï¼ææ¤é FDA å¯¹çº¦ 14 ç§çé¨å¤è½çéå¶ã\nããè¯å°¼è¿ªè®¤ä¸ºï¼æ¤åççç®¡ç¦ä»¤æ¬èº«å¹¶ä¸åæ³ï¼åèå¬çäºå±é©çå°ä¸å¸åºï¼éæ°å½ç±»ãå è®¸æ£è§è¯æ¿åè§è°é ï¼æå¯ä»¥è®©æ°ä¼è·å¾åçç®¡çäº§åã\nããææ¯è¾¾å°äº 2025 å¹´ 8 æåºä»»è¯ºåè¯ºå¾· CEOï¼æ¥æ¿ä»»èå¤å¹´çææ¯ã»å¼é²é«ã»çº¦æ ¹æ£®ã1992 å¹´ä»å¨ç»´ä¹çº³ä»¥æ®éåå ¬å®¤æåèº«ä»½å ¥èè¯ºåè¯ºå¾·ï¼åç» 33 å¹´æåï¼æç»æ§æè¿å®¶å·¨å¤´ã\nãã2015 å¹´ä»åä»»å½é ä¸å¡æ§è¡å¯æ»è£ï¼å ¨é¢æç®¡ç¾å½ä»¥å¤å ¨é¨åä¸çå¾ï¼å¸¦é¢è¯¥æ¿åå®ç°éå®é¢ç¿»åã\nããå¦ä»ï¼ææ¯è¾¾å°æèµè¿å®¶å»çå·¨å¤´ï¼ç´é¢ GLPâ1 èµéæ¿çç«äºï¼ä¸»è¦å¯¹æä¸ºç¤¼æ¥\nããææ¯è¾¾å°è¡¨ç¤ºï¼ä¸æ¹é¢è¦ä¼å Wegovy è¥éï¼åæ¶ç»§ç»æ¨å¨å£æç Wegovy æ¾éï¼ä¸å£åº¦å£æçäº§åä¸ç»©ä¸ååæå¸é¢æãå¦å¤ï¼ä»æ£å å¤§ç åæå ¥ï¼åºå¯¹æªæ¥æ°å¹´å¤æ¬¾ä¸å©å°æçææã\nããä¸è¿°ä¸¾æªè½å¦è½å°ï¼å¯¹ä¿®å¤è¯ºåè¯ºå¾·å¨åå°è¡ç¼ä¸çå½¢è±¡è³å ³éè¦ã\nããè¿å»ä¸å¹´ï¼è¯ºåè¯ºå¾·è¡ä»·ç´¯è®¡ä¸è· 17%ï¼åææ æ® 500 ææ°ä¸æ¶¨ 19%ï¼ç¤¼æ¥è¡ä»·å¤§æ¶¨ 57%ã\nããé«ç\nè´£ä»»ç¼è¾ï¼éæç \nVIPè¯¾ç¨æ¨è\nAPPä¸äº«ç´æ\nçé¨æ¨è\næ¶èµ·24å°æ¶æ»å¨ææ¥ææ°çè´¢ç»èµè®¯åè§é¢ï¼æ´å¤ç²ä¸ç¦å©æ«æäºç»´ç å ³æ³¨ï¼sinafinanceï¼","source":"新浪财经","date":"2026-09-08T07:00:00+00:00","content":"ããè¯ºåè¯ºå¾·\nããä½å¯¹äºå¤è½é¢åå°ä¸å¸åºçä¹±è±¡ï¼ä»å´æåº¦å·æ·¡ãä¸å°ç½çº¢åä¸»è´ä¹°æªç»æ£éªçå¤è½éåç¨æ¥æ¹åç®è¤ç¶æï¼å¥èº«ç±å¥½è ä¹ä¹°æ¥è¿ç±»äº§åï¼å¸æå¿«éåèã\nããææ¯è¾¾å°å¨ãä¸çå¤§åè®¿è°ãææ°ä¸ææå®¢èç®ä¸è¡¨ç¤ºï¼âå¸é¢ä¸æå¤§éè¿ç±»å¤è½äº§åï¼å®ä»¬ä¸å Wegovy çåãä¹ä¸åæä»¬çè°å²ç´ ï¼å®å ¨æ²¡æç»è¿éªè¯ãå å ¶éåªåè¿é¨åå¨ç©å®éªï¼åªè§å¯è¿å¨å¤§é¼ ãå°é¼ èº«ä¸çååºï¼æ ¹æ¬æ²¡æå¼å±äººä½ä¸´åºè¯éªãå»è¯è¡ä¸çç®¡ååå¿ è¦ï¼å ä¸ºè¯ç©ä¼äº§çä¸¥éå¯ä½ç¨ãè¦ç¥éï¼è¯¯ç¨è¯ç©æ¯ä¼è´äººæ»äº¡çãè¿å¯ä¸æ¯ä¹°ä¸ªé«ä»¿å¤é©°å é£ä¹ç®åï¼ä¼å¸¦æ¥å®å®å¨å¨çä¸¥éåæãâ\nããææ¯è¾¾å°è®¤ä¸ºï¼ç¾å½é£åè¯åçç£ç®¡çå±ï¼FDAï¼åºå½å¯¹è¿ç±»å¤è½å®æ½çç®¡ã\nããâè¿äºäº§åæ²¡æç»è¿éªè¯ï¼æä»¥æççæ¡æ¯ï¼æä¸ç¥éå®ä»¬å®ä¸å®å ¨ãæèªå·±ç»å¯¹ä¸ä¼å»åè¿ä¸ªé£é©ãå®ä»¬æè®¸ææï¼æè®¸æèé£é©ï¼ä¹å¯è½ä¸¤è çæ ãä½ä¸ºä»ä¹è¦ç¨èªå·±çèº«ä½åå¥åº·å»åè¿ä¹å¤§çé£é©ï¼â\nããä»è¡¥å éï¼âå½ç¶ï¼æä¸å¦è®¤æªæ¥é¨åå¤è½ååçåºç±è¯ä¼å®æè§èæµè¯ï¼èµ°å® FDA ä»¥ååé¡¹çç®¡æµç¨ãå¦æç¡®å®åå¨å¸åºéæ±ï¼é£å°±å¼å±è¯éªï¼æ¨åºå®å ¨åè§ççæ¬ï¼èä¸æ¯æ¿äººèº«å®å ¨å»èµåãâ\nããåç¤¾äº¤åªä½é£æ½®ãåéè¯ç©èµ°çº¢å¸¦å¨ï¼ä¸»æçç©é»å®¢ä¸å »çåæçå¤è½ï¼ä¾å¦ BPCâ157ãTBâ500ï¼å¸åºç«çãä¸å°æ¶è´¹è å¯å¸æäºå®ä»¬å®ç°æè¡°èãæä¼¤ä¿®å¤ãå¢èçææã\nããæ¤å FDA å°å¤§éæªè·æ¹å¤è½åå ¥ç®¡æ§æ¸ åï¼ç¦æ¢è¯æ¿èªè¡è°é ãäºæ¯æ°ç¾ä¸ç¨æ·è½¬åå®å ¨æ²¡æçç®¡çé»å¸ä¸ç°å¸æ¸ éã\nããé¢å¯¹ç°ç¶ï¼ç¾å½å«çä¸å ¬ä¼æå¡é¨é¨é¿ç½ä¼¯ç¹ã»è¯å°¼è¿ªäºä¸èªç§°æ¯å¤è½çå¿ å®ä½¿ç¨è ï¼ä»æ¨å¨éå¤§æ¿çè½¬åï¼ææ¤é FDA å¯¹çº¦ 14 ç§çé¨å¤è½çéå¶ã\nããè¯å°¼è¿ªè®¤ä¸ºï¼æ¤åççç®¡ç¦ä»¤æ¬èº«å¹¶ä¸åæ³ï¼åèå¬çäºå±é©çå°ä¸å¸åºï¼éæ°å½ç±»ãå è®¸æ£è§è¯æ¿åè§è°é ï¼æå¯ä»¥è®©æ°ä¼è·å¾åçç®¡çäº§åã\nããææ¯è¾¾å°äº 2025 å¹´ 8 æåºä»»è¯ºåè¯ºå¾· CEOï¼æ¥æ¿ä»»èå¤å¹´çææ¯ã»å¼é²é«ã»çº¦æ ¹æ£®ã1992 å¹´ä»å¨ç»´ä¹çº³ä»¥æ®éåå ¬å®¤æåèº«ä»½å ¥èè¯ºåè¯ºå¾·ï¼åç» 33 å¹´æåï¼æç»æ§æè¿å®¶å·¨å¤´ã\nãã2015 å¹´ä»åä»»å½é ä¸å¡æ§è¡å¯æ»è£ï¼å ¨é¢æç®¡ç¾å½ä»¥å¤å ¨é¨åä¸çå¾ï¼å¸¦é¢è¯¥æ¿åå®ç°éå®é¢ç¿»åã\nããå¦ä»ï¼ææ¯è¾¾å°æèµè¿å®¶å»çå·¨å¤´ï¼ç´é¢ GLPâ1 èµéæ¿çç«äºï¼ä¸»è¦å¯¹æä¸ºç¤¼æ¥\nããææ¯è¾¾å°è¡¨ç¤ºï¼ä¸æ¹é¢è¦ä¼å Wegovy è¥éï¼åæ¶ç»§ç»æ¨å¨å£æç Wegovy æ¾éï¼ä¸å£åº¦å£æçäº§åä¸ç»©ä¸ååæå¸é¢æãå¦å¤ï¼ä»æ£å å¤§ç åæå ¥ï¼åºå¯¹æªæ¥æ°å¹´å¤æ¬¾ä¸å©å°æçææã\nããä¸è¿°ä¸¾æªè½å¦è½å°ï¼å¯¹ä¿®å¤è¯ºåè¯ºå¾·å¨åå°è¡ç¼ä¸çå½¢è±¡è³å ³éè¦ã\nããè¿å»ä¸å¹´ï¼è¯ºåè¯ºå¾·è¡ä»·ç´¯è®¡ä¸è· 17%ï¼åææ æ® 500 ææ°ä¸æ¶¨ 19%ï¼ç¤¼æ¥è¡ä»·å¤§æ¶¨ 57%ã\nããé«ç\nè´£ä»»ç¼è¾ï¼éæç \nVIPè¯¾ç¨æ¨è\nAPPä¸äº«ç´æ\nçé¨æ¨è\næ¶èµ·24å°æ¶æ»å¨ææ¥ææ°çè´¢ç»èµè®¯åè§é¢ï¼æ´å¤ç²ä¸ç¦å©æ«æäºç»´ç å ³æ³¨ï¼sinafinanceï¼","confidence":0.9,"diagnostics_url":"/api/diagnose?url=https%3A//finance.sina.com.cn/stock/usstock/c/2026-09-08/doc-inircrnn9212070.shtml%3Ffinpagefr%3Dp_108","quality_bucket":"high","failure_kind":"none","retryable":false,"quality_reason":"High confidence: full text extraction produced 2228 characters.","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 2228 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":2228,"summary_length":2228,"usable_text_length":2228,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":2228,"summary_length":2228}},"tags":[],"format_contract_version":"news_item_formats.v1"}}}